The Ascendance of North America's Sepsis Diagnostics Market

The North America Sepsis Diagnostics Market Size is expected to be valued at USD 466.93 million in 2024 and reach USD 699.84 million by 2029, growing at a CAGR of 8.43 % from 2024 to 2029.

Sepsis diagnostics refers to processes and methods used to identify and diagnose sepsis. Sepsis is an overactive immune response to an infection, which, in severe conditions, results in organ failure, tissue damage, and inflammation. In sepsis, the immune system fights with itself rather than against invaders.

North America Sepsis Diagnostics Marke Report Scope:

• Market Size (2029): USD 699.84 million
• Market Size (2024): USD 466.93 million
• CAGR (2024 to 2029): 8.43 %
• Base Year: 2023
• Forecast Period: 2024 to 2029
• Segments Analysed: By Pathogen, Product, Technology, Method, Usability and Region.
• Geographies Covered: North America, Europe, APAC, Latin America, and Middle East & Africa
• Key Market Players Profiled: bioMérieux SA, T2 Biosystem Inc, Cepheid, Thermo Fisher Scientific Inc., Nanosphere Inc, Abbott Laboratories, Roche Diagnostics Limited, Becton,are playing a dominant role in the North America Sepsis Diagnostics Market.

Browse full details of the report @ https://www.marketdataforecast.com/market-reports/north-america-sepsis-diagnostics-market

Key Insights from The Report:
• Based on Pathogen, the Bacterial Sepsis Segment captured highest share of the global market in 2023.
• Based on Product, the Instruments segment dominated the market in 2023.
• Based on Technology, the Microbiology Segment captured highest share of the global market in 2023.
• Based on Method, the Conventional Diagnostics Segment captured highest share of the global market in 2023.
• Based on Usability, the Laboratory Testing Segment captured highest share of the global market in 2023.

• North America dominated the healthcare analytics market in 2023. Europe accounted for second- highest share of the North America Sepsis Diagnostics Market in 2023 and on the other hand, the Asia-Pacific region is estimated to grow at the fastest CAGR during the forecast period.
• AMD North America Sepsis Diagnostics Market bioMérieux SA, T2 Biosystem Inc, Cepheid, Thermo Fisher Scientific Inc., Nanosphere Inc, Abbott Laboratories, Roche Diagnostics Limited, Becton are dominated the North America Sepsis Diagnostics Market.

The rising prevalence of infectious diseases and the growing senior population with chronic illnesses worldwide contribute majorly to regional market growth. The growing government initiatives for infectious diseases and the government's support towards the R&D activities to develop effective safety therapeutics to treat sepsis and prevent sepsis are primarily driving the regional market growth. The increasing technological advancements in the diagnosis and treatment methods are boosting the sepsis diagnostics market expansion in the North American region. The presence of advanced healthcare infrastructure and growing healthcare expenditure fuel the regional market expansion. The rising incidence of hospital-acquired infections across the region propels the adoption of advanced sepsis diagnostic methods, leading to enhanced market growth opportunities. The growing advancements in sepsis diagnosis, like the evolution of novel biomarkers for the diagnosis of sepsis, are expected to create growth opportunities for the regional market over the forecast period. The increasing prevalence of chronic disease conditions like cardiovascular diseases, which require surgeries and extended stays at hospitals, where these cases are highly prone to sepsis. These conditions and scenarios are rising demand for advanced sepsis diagnostic methods, driving the market growth in developed countries like the U.S. and Canada. The growth in the use of invasive devices like intravenous catheters and breathing tubes, which can act as carriers of infection in patients, is estimated to increase the demand for sepsis diagnostics in the region.

The high costs associated with treating sepsis in U.S. hospitals are a significant factor restraining the market growth in the region. According to an estimation by The Society of Critical Care Medicine (SCCM), the last decade witnessed that sepsis accounted for more than USD 24 billion in hospital expenses, representing 13% of total U.S. hospital costs. The need for awareness and shortage of skilled professionals is estimated to limit the regional market expansion. The presence of limited testing methods with accurate results for sepsis is hindering the market growth opportunities for the regional market. The complex regulatory framework for approving and developing effective and safe diagnostic methods is impeding market expansion across the region.

SEGMENTATION INCLUDED IN THIS REPORT:

By Pathogen:
• Bacterial Sepsis
o Gram-Negative Bacterial Sepsis
o Gram-Positive Bacterial Sepsis
• Fungal Sepsis
• Other Pathogen Infections
By Product:
• Instruments
• Blood Culture Media
• Assay Kits & Reagents
• Software
By Technology:
• Microbiology
• Molecular Diagnostics
• Immunoassays
• Flow Cytometry
• Other Technologies
By Method:
• Conventional Diagnostics
• Automated Diagnostics
By Usability:
• Laboratory Testing
• Point-of-Care Testing
By Country:
• The United States
• Canada
• Rest of North America

TABLE OF CONTENTS:
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Pathogen
5.1.1 Introduction
5.1.2 Bacterial Sepsis
5.1.2.1 Gram-Negative Bacterial Sepsis
5.1.2.2 Gram-Positive Bacterial Sepsis
5.1.3 Fungal Sepsis
5.1.4 Other Pathogen Infections
5.1.5 Y-o-Y Growth Analysis, By Pathogen
5.1.6 Market Attractiveness Analysis, By Pathogen
5.1.7 Market Share Analysis, By Pathogen
5.2 Product
5.2.1 Introduction
5.2.2 Instruments
5.2.3 Blood Culture Media
5.2.4 Assay Kits & Reagents
5.2.5 Software
5.2.6 Y-o-Y Growth Analysis, By Product
5.2.7 Market Attractiveness Analysis, By Product
5.2.8 Market Share Analysis, By Product
5.3 Technology
5.3.1 Introduction
5.3.2 Microbiology
5.3.3 Molecular Diagnostics
5.3.4 Immunoassays
5.3.5 Flow Cytometry
5.3.6 Other Technologies
5.3.7 Y-o-Y Growth Analysis, By Technology
5.3.8 Market Attractiveness Analysis, By Technology
5.3.9 Market Share Analysis, By Technology
5.4 Method
5.4.1 Introduction
5.4.2 Convential Diagnostics
5.4.3 Automated Diagnostics
5.4.4 Y-o-Y Growth Analysis, By Method
5.4.5 Market Attractiveness Analysis, By Method
5.4.6 Market Share Analysis, By Method
5.5 Usability
5.5.1 Introduction
5.5.2 Laboratory Testing
5.5.3 Point-of-Care Testing
5.5.4 Y-o-Y Growth Analysis, By Usability
5.5.5 Market Attractiveness Analysis, By Usability
5.5.6 Market Share Analysis, By Usability
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Pathogen
6.1.3.3 By Product
6.1.3.4 By Technology
6.1.3.5 By Method
6.1.3.6 By Usability
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Pathogen
6.1.4.3 By Product
6.1.4.4 By Technology
6.1.4.5 By Method
6.1.4.6 By Usability
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Pathogen
6.1.5.3 By Product
6.1.5.4 By Technology
6.1.5.5 By Method
6.1.5.6 By Usability
6.2 United States
6.3 Canada
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter's Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 bioMérieux SA
8.1.1 Overview
8.1.2 Pathogen Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 T2 Biosystem Inc
8.3 Cepheid
8.4 Thermo Fisher Scientific Inc.
8.5 Nanosphere Inc
8.6 Abbott Laboratories
8.7 Roche Diagnostics Limited
8.8 Becton, Dickinson and Company
8.9 Bruker Corporation
8.10 Beckman Coulter, Inc
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures

Contact Us:
MarketDataForecast
www.marketdataforecast.com
Phone: +1-888-702-9626
Email: sales@marketdataforecast.com
5th Floor, Trendz Pride, Patrika Nagar Rd Number 1, HUDA Techno Enclave, HITEC City, Hyderabad, Telangana 500081, India

About Us:
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

This release was published on openPR.